The Fund aims to achieve long-term capital growth.
Name | % Net Assets |
---|---|
Total | 4.7% |
Telefonica | 3.9% |
NESTLE SA COMSTK | 3.3% |
Roche Hldgs (genus) | 3.1% |
Novartis (regd) | 2.8% |
Sanofi-aventis | 2.5% |
Anheuser-busch Inbev | 2.2% |
Siemens Ag | 2.2% |
Vivendi | 1.9% |
Carrefour | 1.9% |
Key | % Net Assets |
---|---|
Total | 4.7% |
Telefonica | 3.9% |
NESTLE SA COMSTK | 3.3% |
Roche Hldgs (genus) | 3.1% |
Other | 85% |
Date | 12-Feb-2010 |
---|---|
NAV | 210.97p |
Currency | GBP |
Change | -0.16p |
% | -0.08% |
YTD change | 210.97p |
YTD % | n/a |
Fund Inception | 30/09/2002 |
---|---|
Fund Manager | Richard Wiseman |
TER | 1.60 (31-Oct-2008) |
Minimum Investment | |
---|---|
Initial | £2000 |
Additional | £1,000 |
Savings | £100 |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.08 |
You are here: research